|
SLE Trend: Predictors of Mortality Risk Change in Lupus
|
Over the past 20 years, while the demographics of systemic lupus erythematosus (SLE) hospitalizations have not noticeably changed, the comorbidities that lead to hospitalizations and poor outcomes in SLE have changed.
|
|
Read more
|
|
|
|
Lupus Damage Builds Over Time
|
| A new study assesses the accumulation of steroid-related damage in adults who were diagnosed with lupus as children. In this slideshow, we highlight the findings. |
|
Read more
|
|
|
|
New Treatment Option for Behçet’s Disease
|
| On Friday, the U.S. Food and Drug Administration approved apremilast (Otezla, Celgene) for the treatment of oral ulcers associated with Behçet’s disease, a rare, chronic, multisystem inflammatory condition that affects approximately five in 100,000 people in the U.S. |
|
Read more
|
|
|
